Perceived medication adverse effects and coping strategies reported by chronic heart failure patients

International Journal of Clinical Practice

Volumn 63, Issue 2, 2009, Pages 233-242

  De Smedt, R H E ^a   Denig, P ^a,b   Haaijer Ruskamp, F M ^a,b   Jaarsma, T ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMIODARONE; AMLODIPINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIANGINA PECTORIS AGENT; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBASALATE CALCIUM; CARDIAC GLYCOSIDE; CLOPIDOGREL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL; NITRATE; PHENPROCOUMON; PRAVASTATIN; PROTON PUMP INHIBITOR; RAMIPRIL; SALMETEROL; SPIRONOLACTONE; TRIAMTERENE; UNINDEXED DRUG; CARDIOVASCULAR AGENT; FIBRINOLYTIC AGENT;

AGED; ARTICLE; COLD LIMB; CONSTIPATION; CONTROLLED STUDY; COUGHING; DIZZINESS; DOCTOR PATIENT RELATION; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; HEADACHE; HEALTH BEHAVIOR; HEART DISEASE; HEART FAILURE; HUMAN; IMPOTENCE; INTERVIEW; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; NAUSEA; PATIENT ATTITUDE; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; RASH; SLEEP DISORDER; STRUCTURED QUESTIONNAIRE; UNSPECIFIED SIDE EFFECT; ADAPTIVE BEHAVIOR; ATTITUDE TO HEALTH; CHRONIC DISEASE; CLINICAL TRIAL; COUNSELING; MULTICENTER STUDY; PATIENT EDUCATION; PERCEPTION; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADAPTATION, PSYCHOLOGICAL; AGED; ATTITUDE TO HEALTH; CARDIOVASCULAR AGENTS; CHRONIC DISEASE; COUNSELING; FEMALE; FIBRINOLYTIC AGENTS; HEART FAILURE; HUMANS; MALE; PATIENT EDUCATION AS TOPIC; PERCEPTION;

EID: 58449101234     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2008.01954.x     Document Type: Article

References (36)

1. Komajda M, Lapuerta P, Hermans N et al. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur Heart J 2005 26 : 1653 9.
2. Shi S, Morike K, Klotz U. The clinical implications of ageing for rational drug therapy. Eur J Clin Pharmacol 2008 64 : 183 99.
3. Routledge PA, O'Mahony MS, Woodhouse KW. Adverse drug reactions in elderly patients. Br J Clin Pharmacol 2004 57 : 121 6.
4. Ioannidis JP, Lau J. Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. JAMA 2001 285 : 437 43.
5. Rief W, Avorn J, Barsky AJ. Medication-attributed adverse effects in placebo groups: implications for assessment of adverse effects. Arch Intern Med 2006 166 : 155 60.
6. Wu JR, Moser DK, Lennie TA, Peden AR, Chen YC, Heo S. Factors influencing medication adherence in patients with heart failure. Heart Lung 2008 37 : 8 16.
7. Evangelista L, Doering LV, Dracup K, Westlake C, Hamilton M, Fonarow GC. Compliance behaviors of elderly patients with advanced heart failure. J Cardiovasc Nurs 2003 18 : 197 206.
8. Hope CJ, Wu J, Tu W, Young J, Murray MD. Association of medication adherence, knowledge, and skills with emergency department visits by adults 50 years or older with congestive heart failure. Am J Health Syst Pharm 2004 61 : 2043 9.
9. Gehi AK, Ali S, Na B, Whooley MA. Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. Arch Intern Med 2007 167 : 1798 803.
10. Ho PM, Magid DJ, Shetterly SM et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J 2008 155 : 772 9.
11. Jaarsma T, van der Wal MH, Hogenhuis J et al. Design and methodology of the COACH study: a multicenter randomised Coordinating study evaluating Outcomes of Advising and Counselling in Heart failure. Eur J Heart Fail 2004 6 : 227 33.
12. Jaarsma T, van der Wal MH, Lesman-Leegte I et al. Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). Arch Intern Med 2008 168 : 316 24.
13. Gandhi TK, Weingart SN, Borus J et al. Adverse drug events in ambulatory care. N Engl J Med 2003 348 : 1556 64.
14. Weingart SN, Gandhi TK, Seger AC et al. Patient-reported medication symptoms in primary care. Arch Intern Med 2005 165 : 234 40.
15. Gurwitz JH, Field TS, Harrold LR et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003 289 : 1107 16.
16. Lakhdar R, Al-Mallah MH, Lanfear DE. Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: a systematic review and meta-analysis of randomized controlled trials. J Card Fail 2008 14 : 181 8.
17. Kostis JB, Shelton BJ, Yusuf S et al. Tolerability of enalapril initiation by patients with left ventricular dysfunction: results of the medication challenge phase of the Studies of Left Ventricular Dysfunction. Am Heart J 1994 128 : 358 64.
18. Young JB, Dunlap ME, Pfeffer MA et al. Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials. Circulation 2004 110 : 2618 26.
19. Kjekshus J, Apetrei E, Barrios V et al. Rosuvastatin in older patients with systolic heart failure. N Engl J Med 2007 357 : 2248 61.
20. Field TS, Gurwitz JH, Harrold LR et al. Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc 2004 52 : 1349 54.
21. Martinez-Selles M, Garcia Robles JA, Munoz R et al. Pharmacological treatment in patients with heart failure: patients knowledge and occurrence of polypharmacy, alternative medicine and immunizations. Eur J Heart Fail 2004 6 : 219 26.
22. Rogers A, Addington-Hall JM, McCoy AS et al. A qualitative study of chronic heart failure patients' understanding of their symptoms and drug therapy. Eur J Heart Fail 2002 4 : 283 7.
23. Gandhi TK, Burstin HR, Cook EF et al. Drug complications in outpatients. J Gen Intern Med 2000 15 : 149 54.
24. Berry C, McMurray J. A review of quality-of-life evaluations in patients with congestive heart failure. Pharmacoeconomics 1999 16 : 247 71.
25. Vassallo P, Trohman RG. Prescribing amiodarone: an evidence-based review of clinical indications. JAMA 2007 298 : 1312 22.
26. Loke YK, Derry S, Aronson JK. A comparison of three different sources of data in assessing the frequencies of adverse reactions to amiodarone. Br J Clin Pharmacol 2004 57 : 616 21.
27. Oladimeji O, Farris KB, Urmie JG, Doucette WR. Risk factors for self-reported adverse drug events among Medicare enrollees. Ann Pharmacother 2008 42 : 53 61.
28. Green JL, Hawley JN, Rask KJ. Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population? Am J Geriatr Pharmacother 2007 5 : 31 9.
29. van den Bemt PM, Egberts AC, Lenderink AW et al. Risk factors for the development of adverse drug events in hospitalized patients. Pharm World Sci 2000 22 : 62 6.
30. van der Wal MH, Jaarsma T, Moser DK, Veeger NJ, van Gilst WH, van Veldhuisen DJ. Compliance in heart failure patients: the importance of knowledge and beliefs. Eur Heart J 2006 27 : 434 40.
31. van der Wal MH, Jaarsma T, van Veldhuisen DJ. Non-compliance in patients with heart failure; how can we manage it? Eur J Heart Fail 2005 7 : 5 17.
32. Stromberg A. Patient-related factors of compliance in heart failure: some new insights into an old problem. Eur Heart J 2006 27 : 379 81.
33. Chao J, Nau DP, Aikens JE. Patient-reported perceptions of side effects of antihyperglycemic medication and adherence to medication regimens in persons with diabetes mellitus. Clin Ther 2007 29 : 177 80.
34. Institute of Medicine (IOM). Crossing the Quality Chasm: A new Health System for the 21st Century. Washington, DC : National Academy Press: Institute of Medicine, 2001.
35. Bent S, Padula A, Avins AL. Brief communication: better ways to question patients about adverse medical events: a randomized, controlled trial. Ann Intern Med 2006 144 : 257 61.
36. Jarernsiripornkul N, Krska J, Capps PA, Richards RM, Lee A. Patient reporting of potential adverse drug reactions: a methodological study. Br J Clin Pharmacol 2002 53 : 318 25.